Hap Trading, LLC Pds Biotechnology Corp Transaction History
Hap Trading, LLC
- $872 Billion
- Q3 2024
A detailed history of Hap Trading, LLC transactions in Pds Biotechnology Corp stock. As of the latest transaction made, Hap Trading, LLC holds 151,700 shares of PDSB stock, worth $238,169. This represents 0.01% of its overall portfolio holdings.
Number of Shares
151,700Holding current value
$238,169% of portfolio
0.01%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding PDSB
# of Institutions
64Shares Held
4.32MCall Options Held
253KPut Options Held
70.4K-
Vanguard Group Inc Valley Forge, PA1.52MShares$2.39 Million0.0% of portfolio
-
Black Rock Inc. New York, NY487KShares$764,5380.0% of portfolio
-
Geode Capital Management, LLC Boston, MA415KShares$651,7270.0% of portfolio
-
Inspirion Wealth Advisors, LLC344KShares$540,6980.18% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny234KShares$367,7080.0% of portfolio
About PDS Biotechnology Corp
- Ticker PDSB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,458,700
- Market Cap $44.7M
- Description
- PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product candidate is PDS0101 (HPV16), which is in Phase II clinical trial provides a first line treatment for the recurrent/metastatic head and neck cancer, human papillomavirus associated malignancies...